Leishmania mitochondrial small ribosomal subunit (30S SSU)

The Leishmania mitochondrial small ribosomal subunit, frequently designated as the 30S subunit, is a fundamental component of the mitochondrial protein synthesis apparatus in kinetoplastid parasites. It associates with the 40S large subunit to form a functional 50S mitochondrial ribosome (mitoribosome), which is characterized by an exceptionally high protein-to-RNA ratio and a minimal 9S ribosomal RNA [1, 8]. This subunit is indispensable for the translation of essential mitochondrial genes that encode components of the parasite's respiratory chain, thereby supporting energy production and survival within the host [12]. Historically, the 30S subunit was considered the primary target of aminoglycoside antibiotics such as paromomycin, which bind to the ribosomal A-site to induce translational errors [11, 14]. However, contemporary structural biology has clarified that while these drugs can interact with the mitochondrial subunit, their potent antileishmanial activity is primarily driven by the inhibition of the cytosolic 40S ribosomal subunit [9, 15]. Despite this shift in understanding the primary mechanism of existing drugs, the 30S mitochondrial subunit remains a high-priority target for drug discovery due to its unique structural features that distinguish it from human mitochondrial and cytosolic ribosomes [14, 17].

Other names

Leishmania 30S ribosomal subunitLeishmania mitochondrial 30S subunitLeishmania 9S ribosomal subunitLeishmania mitochondrial small subunitLmr SSU

Inhibition of mitochondrial protein synthesis by binding to the decoding center (A-site) of the 30S subunit, leading to translational misreading and disruption of the mitochondrial respiratory chain.